Convention on Biological Diversity

Convention on Biological Diversity (CBD) is an international legal agreement aimed at conserving biodiversity, promoting sustainable use of its components, and ensuring fair and equitable sharing of benefits arising from the use of genetic resources. It was opened for signature at the Earth Summit in Rio de Janeiro in 1992 and entered into force on 29 December 1993.
Overview[edit]
The Convention on Biological Diversity is a pivotal international treaty that has three main objectives: the conservation of biological diversity, the sustainable use of its components, and the fair and equitable sharing of benefits arising from genetic resources. This comprehensive agreement covers all ecosystems, species, and genetic resources. It links traditional conservation efforts to the economic goal of using biological resources sustainably. It sets principles for the fair and equitable sharing of benefits, with significant attention to the rights of indigenous peoples and local communities over their traditional knowledge and practices.
History[edit]
The idea of the Convention on Biological Diversity was born from the growing recognition of the global decline in biodiversity and the need to safeguard it. The negotiation process was initiated by the United Nations Environment Programme (UNEP) and culminated in its adoption at the Earth Summit in 1992, one of the largest gatherings of world leaders in history, which addressed pressing issues like climate change and biodiversity loss.
Key Provisions[edit]
The CBD is structured around its three main goals: conservation, sustainable use, and benefit-sharing. It emphasizes the need for countries to develop national biodiversity strategies and action plans. The Convention also establishes principles for the access to genetic resources and the sharing of benefits, requiring that such access be subject to prior informed consent and mutually agreed terms.
Protocols[edit]
The CBD has been supplemented by two additional agreements:
- The Cartagena Protocol on Biosafety to the Convention on Biological Diversity, which addresses the safe handling, transport, and use of living modified organisms (LMOs) resulting from modern biotechnology that may have adverse effects on biodiversity.
- The Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits Arising from their Utilization, which provides a transparent legal framework for the effective implementation of one of the CBD’s three objectives: the fair and equitable sharing of benefits arising out of the utilization of genetic resources.
Challenges and Criticisms[edit]
Despite its comprehensive framework and widespread ratification, the CBD faces challenges in implementation, including insufficient funding, the complexity of biodiversity issues, and the need for stronger political commitment in some countries. Critics also point to the slow pace of progress on some of its objectives, particularly in relation to the protection of biodiversity hotspots and the equitable sharing of benefits.
Impact and Future Directions[edit]
The Convention on Biological Diversity has played a crucial role in raising global awareness of the importance of biodiversity and has led to significant national and international efforts to conserve biological diversity. Future directions for the CBD include enhancing the integration of biodiversity considerations into other sectors of the economy, strengthening the implementation of its protocols, and addressing emerging issues such as climate change and its impact on biodiversity.

This article is a environment-related stub. You can help WikiMD by expanding it!
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99 with insurance
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian